THERAPEUTIC COMPOUNDS
    24.
    发明申请
    THERAPEUTIC COMPOUNDS 有权
    治疗化合物

    公开(公告)号:US20090270386A1

    公开(公告)日:2009-10-29

    申请号:US12427821

    申请日:2009-04-22

    CPC分类号: C07D233/40

    摘要: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein G, B, D, and Y are as described. Methods, compositions, and medicaments related thereto are also disclosed.

    摘要翻译: 公开了包含其药学上可接受的盐或其前药的化合物,其中G,B,D和Y如上所述。 还公开了与之相关的方法,组合物和药物。

    5-thiopiperdinyl prostaglandin E analogs
    29.
    发明授权
    5-thiopiperdinyl prostaglandin E analogs 有权
    5-硫代哌啶基前列腺素E类似物

    公开(公告)号:US07435746B2

    公开(公告)日:2008-10-14

    申请号:US10564829

    申请日:2005-05-16

    IPC分类号: A61K31/45

    CPC分类号: C07D211/76 C07F9/59

    摘要: A compound comprising or a pharmaceutically acceptable salt or a prodrug thereof is disclosed herein. Y and R are described in detail herein A compound having an ω chain comprising or a derivative thereof, or a pharmaceutically acceptable salt or a prodrug thereof, is disclosed. Derivatives, salts and prodrugs are identified and described in detail. Methods of treating certain conditions or diseases, and compositions and medicaments related thereto are also contemplated.

    摘要翻译: 本文公开了包含其药学上可接受的盐或其前药的化合物。 Y和R在此详细描述了具有ω链或其衍生物的化合物或其药学上可接受的盐或前体药物。 衍生物,盐和前药被详细鉴定和描述。 还考虑了治疗某些病症或疾病的方法,以及与之相关的组合物和药物。